Currently out of the existing stock ratings of Lee Lueder, 4 are a HOLD (30.77%), 9 are a BUY (69.23%).

Lee Lueder

Work Performance Price Targets & Ratings Chart

Analyst Lee Lueder works with a stock forecast success ratio of 86.11% fulfilled within 81.67 days on average.

Lee Lueder’s has documented 26 price targets and ratings displayed on 3 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on CRL, Charles River Laboratories at 18-Dec-2023.

Wall Street Analyst Lee Lueder

Analyst best performing recommendations are on IQV (IQVIA HOLDINGS).
The best stock recommendation documented was for CRL (CHARLES RIVER LABORATORIES) at 11/9/2023. The price target of $215 was fulfilled within 34 days with a profit of $45.53 (26.87%) receiving and performance score of 7.9.

Average potential price target upside

CRL Charles River Laboratories CTLT Catalent IQV IQVIA Holdings

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

290

$35.08 (13.76%)

480

26 days ago

5/7 (71.43%)

$27.87 (10.63%)

136

Buy

265

$10.08 (3.95%)

1 months 29 days ago

3/3 (100%)

$19.6 (7.99%)

114

Buy

280

$25.08 (9.84%)

250

1 months 29 days ago

2/4 (50%)

$34.6 (14.10%)

128

Buy

268

$13.08 (5.13%)

256

1 months 29 days ago

7/9 (77.78%)

$22.6 (9.21%)

95

Buy

245

$-9.92 (-3.89%)

215

3 months 26 days ago

5/6 (83.33%)

$16.91 (7.41%)

66

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Lee Lueder is most bullish on?

Potential upside of $-9.92 has been obtained for CRL (CHARLES RIVER LABORATORIES)

What Year was the first public recommendation made by Lee Lueder?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?